+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cell and Gene Therapy Tools, and Reagents: Global Markets

  • ID: 5131042
  • Report
  • July 2020
  • Region: Global
  • 71 Pages
  • BCC Research
1 of 5

FEATURED COMPANIES

  • Abcam
  • Athersys Inc.
  • Bio-Rad Laboratories
  • Cellgenix
  • Luminex Corp.
  • Millipore Sigma
  • MORE

Report Scope:

The scope of this study encompasses an investigation of the market's cell and gene therapy tools such as GMP proteins, media, cell separation and activation reagents, viral and non-viral, cytokine release syndrome monitoring products, GMP antibodies, leukapheresis instrumentation, immunoassays (multiplex and singleplex) and bioreactors. This research analyzes each tool type, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next five years. Technological issues, including the latest trends, are discussed. The publisher analyzes the industry on a worldwide basis, from both application and demand perspectives, in the major regions of the world.

Report Includes:

  • 77 data tables
  • An overview of the global market for immunoassay-based cell and gene therapy tools, and reagents within the life sciences industry
  • Analyses of the global market trends, with data corresponding to market size for 2017-2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Information about in-vitro diagnostics (IVD), its background and importance of IVD testing
  • Discussion on the prevalence of the infectious disease, metabolic disorders and chronic ailments as drivers of immunoassay testing market
  • Description of recent technologies such as chemiluminescent immunoassays (CLIA), fluorescent immunoassays, multiplex assays, and rapid diagnostic technologies
  • Evaluation of the market potential for immunoassay-based cell and gene therapy tools and reagents, current market size and market forecast, and market share analysis of the leading players engaged
  • Patent review and new developments, R&D efforts, industrial changes with emphasis on recent investments, and current state of the immunoassay technology
  • Company profiles of the key market participants, including Bio-Rad Laboratories, Cytiva Life Sciences, Luminex Corp., Millipore Sigma, Thermo Fisher Scientific and STEMCELL Technologies
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abcam
  • Athersys Inc.
  • Bio-Rad Laboratories
  • Cellgenix
  • Luminex Corp.
  • Millipore Sigma
  • MORE

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

  • Evolution and Expansion of Therapies
  • Role for CRISPR?
  • New Vectors, New Solutions
  • Cell Therapy is Growing
  • Payor Policy Proves Potential
  • Coronavirus Crown?

Chapter 3 Market and Technology Background

  • Overview: Beginnings and Current State of Cell and Gene Therapy
  • Cell Therapy
  • Gene Therapy
  • Types of Cell and Gene Therapy
  • Gene Therapy
  • Cell Therapy
  • Common Equipment Used
  • Industry Structure
  • Major Companies and Market Share

Chapter 4 Market Breakdown by Region

  • Cell and Gene Therapy Equipment

Chapter 5 Market Breakdown by End User

Chapter 6 Government Regulations

  • Scope of Regulations on Gene Therapy
  • Viral and Non-Viral Vectors
  • Media
  • GMP Proteins and Antibodies
  • Cell Therapy
  • Leukapheresis
  • Cell Therapy, Gene Therapy and the EMA

Chapter 7 Patent Review/New Developments

  • Cell and Gene Therapy R&D
  • Academia
  • Industrial Changes
  • Recent Investments
  • Technology
  • Current State of Technology

Chapter 8 Analysis of Market Opportunities

  • Case Studies of Cell and Gene Therapy
  • Clinical Diagnostics
  • Pharmaceutical/Biotechnology

Chapter 9 Company Profiles

  • Abcam
  • Adverum Biotechnologies
  • Athersys Inc.
  • Avrobio
  • Bio-Rad Laboratories
  • Bio-Techne
  • Cellgenix
  • Cytiva Life Sciences
  • Luminex Corp.
  • Mesoblast Ltd.
  • Millipore Sigma
  • Miltenyi Biotec
  • Organicell
  • Quanterix
  • Sartorius
  • Stemcell Technologies
  • Thermo Fisher

List of Tables
Summary Table: Global Market for Life Science Tools, by Region, Through 2024
Table 1: Global Market for Academic Life Science Tools, by Region, Through 2024
Table 2: Global Market for Clinical Life Science Tools, by Region, Through 2024
Table 3: Global Market for Biotech Life Science Tools, by Region, Through 2024
Table 4: Global Market for GMP Proteins, by Region, Through 2024
Table 5: Global Market for Academic GMP Proteins, by Region, Through 2024
Table 6: Global Market for Clinical GMP Proteins, by Region, Through 2024
Table 7: Global Market for Biotech GMP Proteins, by Region, Through 2024
Table 8: Global Market for Media, by Region, Through 2024
Table 9: Global Market for Academic Media, by Region, Through 2024
Table 10: Global Market for Clinical Media, by Region, Through 2024
Table 11: Global Market for Biotech Media, by Region, Through 2024
Table 12: Global Market for Cell Separation, by Region, Through 2024
Table 13: Global Market for Academic Cell Separation, by Region, Through 2024
Table 14: Global Market for Biotech Cell Separation, by Region, Through 2024
Table 15: Global Market for Clinical Cell Separation, by Region, Through 2024
Table 16: Global Market for Gene Vectors, by Region, Through 2024
Table 17: Global Market for Academic Gene Vectors, by Region, Through 2024
Table 18: Global Market for Clinical Gene Vectors, by Region, Through 2024
Table 19: Global Market for Biotech Gene Vectors, by Region, Through 2024
Table 20: Global Market for Cytokine Release Syndrome Testing, by Region, Through 2024
Table 21: Global Market for Academic Cytokine Release Syndrome Testing, by Region, Through 2024
Table 22: Global Market for Clinical Cytokine Release Syndrome Testing, by Region, Through 2024
Table 23: Global Market for Biotech Cytokine Release Syndrome Testing, by Region, Through 2024
Table 24: Global Market for GMP Antibodies, by Region, Through 2024
Table 25: Global Market for Academic GMP Antibodies, by Region, Through 2024
Table 26: Global Market for Clinical GMP Antibodies, by Region, Through 2024
Table 27: Global Market for Biotech GMP Antibodies, by Region, Through 2024
Table 28: Global Market for Leukapheresis, by Region, Through 2024
Table 29: Global Market for Academic Leukapheresis, by Region, Through 2024
Table 30: Global Market for Biotech Leukapheresis, by Region, Through 2024
Table 31: Global Market for Clinical Leukapheresis, by Region, Through 2024
Table 32: Global Market for Bioreactors, by Region, Through 2024
Table 33: Global Market for Academic Bioreactors, by Region, Through 2024
Table 34: Global Market for Biotech Bioreactors, by Region, Through 2024
Table 35: Global Market for Clinical Bioreactors, by Region, Through 2024
Table 36: Global Market for Research Use-Only Immunoassays, by Region, Through 2024
Table 37: Global Market for Academic Research Use-Only Immunoassays, by Region, Through 2024
Table 38: Global Market for Clinical Research Use-Only Immunoassays, by Region, Through 2024
Table 39: Global Market for Biotech Research Use-Only Immunoassays, by Region, Through 2024
Table 40: Global Market for Research Use-Only Multiplex Immunoassays, by Region, Through 2024
Table 41: Global Market for Academic Research-Use Only Multiplex Immunoassays, by Region, Through 2024
Table 42: Global Market for Clinical Research Use-Only Multiplex Immunoassays, by Region, Through 2024
Table 43: Global Market for Biotech Research Use-Only Multiplex Immunoassays, by Region, Through 2024
Table 44: Global Market for Cancer Life Science Tools, by Region, Through 2024
Table 45: Global Market for Blood Disorder Life Science Tools, by Region, Through 2024
Table 46: Global Market for Life Science Tools for Other Diseases, by Region, Through 2024
Table 47: Global Market for Cancer GMP Proteins, by Region, Through 2024
Table 48: Global Market for Blood Disorder GMP Proteins, by Region, Through 2024
Table 49: Global Market for GMP Proteins for Other Diseases, by Region, Through 2024
Table 50: Global Market for Cancer Media, by Region, Through 2024
Table 51: Global Market for Blood Disorder Media, by Region, Through 2024
Table 52: Global Market for Media for Other Diseases, by Region, Through 2024
Table 53: Global Market for Cancer Cell Separation, by Region, Through 2024
Table 54: Global Market for Blood Disorder Cell Separation, by Region, Through 2024
Table 55: Global Market for Cell Separation for Other Diseases, by Region, Through 2024
Table 56: Global Market for Cancer Gene Vectors, by Region, Through 2024
Table 57: Global Market for Blood Disorder Gene Vectors, by Region, Through 2024
Table 58: Global Market for Gene Vectors for Other Diseases, by Region, Through 2024
Table 59: Global Market for Cancer Cytokine Release Syndrome Testing, by Region, Through 2024
Table 60: Global Market for Blood Disorder Cytokine Release Testing, by Region, Through 2024
Table 61: Global Market for Cytokine Release Testing for Other Diseases, by Region, Through 2024
Table 62: Global Market for Cancer GMP Antibodies, by Region, Through 2024
Table 63: Global Market for Blood Disorder GMP Antibodies, by Region, Through 2024
Table 64: Global Market for GMP Antibodies for Other Diseases, by Region, Through 2024
Table 65: Global Market for Cancer Leukapheresis, by Region, Through 2024
Table 66: Global Market for Blood Disorder Leukapheresis, by Region, Through 2024
Table 67: Global Market for Leukapheresis for Other Diseases, by Region, Through 2024
Table 68: Global Market for Cancer Bioreactors, by Region, Through 2024
Table 69: Global Market for Blood Disorder Bioreactors, by Region, Through 2024
Table 70: Global Market for Bioreactors for Other Diseases, by Region, Through 2024
Table 71: Global Market for Cancer Immunoassays, by Region, Through 2024
Table 72: Global Market for Blood Disorder Immunoassays, by Region, Through 2024
Table 73: Global Market for Immunoassays for Other Diseases, by Region, Through 2024
Table 74: Global Market for Cancer Multiplex Immunoassays, by Region, Through 2024
Table 75: Global Market for Blood Disorder Multiplex Immunoassays, by Region, Through 2024
Table 76: Global Market for Multiplex Immunoassays for Other Diseases, by Region, Through 2024

List of Figures
Summary Figure: Global Market for Life Science Tools, by Region, 2017-2024

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abcam
  • Athersys Inc.
  • Bio-Rad Laboratories
  • Cellgenix
  • Luminex Corp.
  • Millipore Sigma
  • MORE

Reasons for Doing this Study:

Gene and cell therapy are emerging as important tools to treat human health. Techniques such as CAR-T therapy have emerged as key ways of treating many different types of cancers. The promise of gene therapy using technologies such as CRISPR is starting to be realized in clinical trials, and markets are scaling up to treat other diseases as well, particularly rare gene-based diseases. As these therapies are coming to the fore, a new market for tools to develop these therapies using standard methodologies is emerging. This report will cover what those tools are, how they impact the larger life science tools market, and how they will evolve over the next five years.

Note: Product cover images may vary from those shown
5 of 5
  • Abcam
  • Adverum Biotechnologies
  • Athersys Inc.
  • Avrobio
  • Bio-Rad Laboratories
  • Bio-Techne
  • Cellgenix
  • Cytiva Life Sciences
  • Luminex Corp.
  • Mesoblast Ltd.
  • Millipore Sigma
  • Miltenyi Biotec
  • Organicell
  • Quanterix
  • Sartorius
  • Stemcell Technologies
  • Thermo Fisher
Note: Product cover images may vary from those shown
Adroll
adroll